Abingworth’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.38M | Hold |
1,201,506
| – | – | 0.78% | 10 |
|
|
2022
Q3 | $2.01M | Sell |
1,201,506
-1
| -0% | -$2 | 0.69% | 13 |
|
|
2022
Q2 | $3.17M | Hold |
1,201,507
| – | – | 1.01% | 11 |
|
|
2022
Q1 | $3.97M | Buy |
1,201,507
+514,667
| +75% | +$1.7M | 1.12% | 11 |
|
|
2021
Q4 | $4.22M | Hold |
686,840
| – | – | 1.02% | 14 |
|
|
2021
Q3 | $9.5M | Hold |
686,840
| – | – | 2.16% | 12 |
|
|
2021
Q2 | $11.6M | Hold |
686,840
| – | – | 3.6% | 10 |
|
|
2021
Q1 | $13M | Hold |
686,840
| – | – | 4.48% | 10 |
|
|
2020
Q4 | $19.9M | Hold |
686,840
| – | – | 6.8% | 4 |
|
|
2020
Q3 | $25.8M | Hold |
686,840
| – | – | 5.51% | 4 |
|
|
2020
Q2 | $22.8M | Buy |
686,840
+222,222
| +48% | +$7.37M | 6.37% | 5 |
|
|
2020
Q1 | $15.7M | Hold |
464,618
| – | – | 10.41% | 4 |
|
|
2019
Q4 | $19.9M | Buy |
464,618
+153,333
| +49% | +$6.58M | 9.63% | 5 |
|
|
2019
Q3 | $6.91M | Hold |
311,285
| – | – | 4.37% | 5 |
|
|
2019
Q2 | $12.1M | Hold |
311,285
| – | – | 4.66% | 5 |
|
|
2019
Q1 | $9.62M | Hold |
311,285
| – | – | 8.61% | 4 |
|
|
2018
Q4 | $7.98M | Buy |
+311,285
| New | +$7.98M | 7.25% | 4 |
|